Literature DB >> 460262

Fatty acid supplementation in cystic fibrosis.

U Berg, A Kallner, E Kusoffsky, B Strandvik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 460262

Source DB:  PubMed          Journal:  Monogr Paediatr        ISSN： 0077-0914


× No keyword cloud information.
  3 in total

1.  Pathological regulation of arachidonic acid release in cystic fibrosis: the putative basic defect.

Authors:  J Carlstedt-Duke; M Brönnegård; B Strandvik
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

2.  A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice.

Authors:  S D Freedman; M H Katz; E M Parker; M Laposata; M Y Urman; J G Alvarez
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

3.  Ceramide in cystic fibrosis: a potential new target for therapeutic intervention.

Authors:  Gabriella Wojewodka; Juan B De Sanctis; Danuta Radzioch
Journal:  J Lipids       Date:  2010-12-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.